Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Ann Surg Oncol. 2022 Sep;29(9):6049-6083. doi: 10.1245/s10434-022-11356-z. Epub 2022 Feb 25.
No abstract available

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures / adverse effects
  • Humans
  • Hyperthermia, Induced* / adverse effects
  • Hyperthermic Intraperitoneal Chemotherapy
  • Peritoneal Neoplasms* / surgery